Since its establishment in 2010, Cellbion has been growing up with customers.
- Sep. 2018
Awarded with Minister Industry Award by Ministry of Science and Technology (No. 25635)
- Aug. 2018
Approved clinical phase 1 trial of Tc-99m-MSA (KFDA, No. 31789)
- May. 2018
Selected as a promising bio-IP business (core technology development business of biomedical device industry) by Ministry of Commerce, Industry and Energy
- April. 2018
Signed a contract with a stock listing supervisor (Korea Investment & Securities Co.,Ltd)
- Feb. 2018
Selected as a new drug development project by the Ministry of Health and Welfare
- Jan. 2017
Registered Wholesale Drug Distributor License
- Jan. 2017
Registered License for Cosmetics Manufacturer
- Dec. 2016
Awarded with 2016 Minister Award for Excellent Bio R&D company by the Ministry of Trade, Industry and Energy, Republic of Korea
- May. 2016
Establishment of Bio R&D Center at Healthcare Innovation Park in SNU Bundang Hospital
- Dec. 2015
Project MSA is designated as Pharm-Navi No. 5 (Commercialization and Globalization Support Program) by Ministry of Food and Drug Safety (MFDS)
- Jul. 2015
Cellbion Co., Ltd. annexed R&D Lab of recognition (Ministry of Science, ICT and Future Planning/Korean Industrial Technology Association)
- Jun. 2015
Establishment of Pharmaceutical Research Institute transferred at SNU Cancer Research Institute, Seoul, Korea
- Jun. 2015
Accredited as Venture Company by Korean Venture Capital Association
- Oct. 2014
Entered into technology transfer agreement for Ga68 NOTA-MSA KIT with Seoul National University (SNU) R&DB Foundation
- Jul. 2010
Establishment of CellBion Co., Ltd.